GlassScriptPhysician profile
Jennifer C Dyer
NPI 1194246876
$1,781.96
in general payments reported to CMS, 2019-2025
19 companies · $580 in 2025
The $580 reported for 2025 was more than what 77% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $28.74 · 2022: $93.99 · 2023: $574 · 2024: $505 · 2025: $580.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,659.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,659.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $311.52 | 2023-2025 | Mounjaro, Jardiance |
| Novo Nordisk INC | $246.31 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Novartis Pharmaceuticals Corporation | $238.90 | 2022-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $229.94 | 2023-2025 | Xifaxan, Trulance |
| Astrazeneca Pharmaceuticals LP | $146.42 | 2024 | Airsupra, Farxiga, Breztri |
| Abbvie INC. | $134.69 | 2022-2024 | |
| Radius Health, INC. | $105.87 | 2023-2024 | Tymlos |
| Bayer Healthcare Pharmaceuticals INC. | $84.31 | 2023-2025 | |
| Xeris Pharmaceuticals, INC. | $59.21 | 2023-2025 | Gvoke Hypopen |
| Otsuka America Pharmaceutical, INC. | $55.46 | 2025 | Rexulti |
| Amgen INC. | $31.11 | 2024-2025 | Otezla, Repatha, Otezla |
| Glaxosmithkline, LLC. | $22.43 | 2023 | Shingrix, Arexvy |
| Pfizer INC. | $21.38 | 2023 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $18.75 | 2025 | Caplyta |
| Azurity Pharmaceuticals, INC. | $17.76 | 2023 | Horizant |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $16.05 | 2024 | Cologuard Collection Kit |
| Eisai INC. | $14.76 | 2021 | |
| Mylan Specialty L.P. | $13.98 | 2021 | |
| Janssen Pharmaceuticals, INC | $13.11 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Dyer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.